Business
Notification of New Zealand Patent Grant Allowance
Notification of New Zealand Patent Grant Allowance.
About this update from Valirx Plc
[{"type":"text","content":"\n \nRNS Number : 4461F ValiRx PLC 28 July 2016 \n\n \n \n \nValiRx Plc\n(\"ValiRx\" or \"the Company\")\n \nValiSeek Extends its International Patent Coverage for VAL401\nNotification of New Zealand Patent Grant Allowance\n \nLondon, UK., 28 July 2016: ValiRx Plc (AIM: VAL), a life science company, which focuses on clinical stage cancer therapeutic development, taking proprietary & novel technology for precision medicines towards commercialisation and partnering, is pleased to announce that ValiSeek Limited, the joint venture between ValiRx and Tangent Reprofiling Limited (\"Tangent\") has received notification of a New Zealand Patent Grant Allowance.\nNotification from the New Zealand Patent Office advises that the patent, granted in the US as patent US9072743 on 14th May 2015, has received allowance of grant in New Zealand. This patent covers both the formulation of VAL401 and its use as a treatment against hormone-related cancers, including lung cancer.\nDr Suzanne Dilly, CEO of ValiSeek Limited, commented: \"This is the first non-US patent grant allowance received for the VAL401 project and as such, it provides an international validation of the programme to support world-wide commercialisation\".\nThis announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.\n*** ENDS ***\n \nFor more information, please contact:\n \n\n\n\n\nValiRx plc\n\n\nTel: +44 (0) 20 3008 4416\nwww.valirx.com\n\n\n\n\nDr Satu Vainikka, Chief Executive\n\n\nTel: +44 (0) 20 3008 4416\n\n\n\n\nTarquin Edwards, Head of Communications.\n\n\nTel: +44 (0) 7879 458 364\[email protected]\n\n\n\n\nMark Treharne, Corporate Development Manager\n\n\nTel: +44 (0) 7736 564 686\[email protected]\n\n\n\n\n\n\n\n\n\n\n\n\nCairn Financial Advisers LLP (Nominated Adviser)\n\n\nTel: +44 (0) 20 7148 7900\n\n\n\n\nLiam Murray / Jo Turner\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nNorthland Capital Partners Limited (Joint Broker)\n\n\nTel: +44 (0) 203 861 6625\n\n\n\n\nPatrick Claridge / David Hignell (Corporate Finance)\nJohn Howes / Abigail Wayne (Broking)\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nBeaufort Securities Limited (Joint Broker)\n\n\nTel: +44 (0) 207 382 8300\n\n\n\n\nJon Belliss\n\n\n\n\n\n\n\n \nNotes for Editors \nAbout ValiSeek\nValiSeek Limited (\"ValiSeek\") is a j...